These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9008918)

  • 41. Contraceptive use among women admitted with abortion in Nairobi.
    Ojwang' SB; Omuga B
    East Afr Med J; 1991 Mar; 68(3):197-203. PubMed ID: 2070755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brazil investigates drug's possible link with birth defects.
    Rocha J
    BMJ; 1994 Sep; 309(6957):757-8. PubMed ID: 7950553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Women hospitalized due to abortion in a maternity teaching hospital in Recife, Brazil].
    da Ramos KS; Ferreira AL; de Souza AI
    Rev Esc Enferm USP; 2010 Sep; 44(3):605-10. PubMed ID: 20964034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induced abortion in maternal and child health centres in a general family planning programme in Cap Bon, Tunisia.
    de Schampheleire I
    Trop Doct; 1982 Apr; 12(2):77-80. PubMed ID: 7080173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytotec and abortion: the police, the vendors and women].
    Diniz D; Madeiro A
    Cien Saude Colet; 2012 Jul; 17(7):1795-804. PubMed ID: 22872341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal trends and spatial distribution of unsafe abortion in Brazil, 1996-2012.
    Martins-Melo FR; Lima Mda S; Alencar CH; Ramos AN; Carvalho FH; Machado MM; Heukelbach J
    Rev Saude Publica; 2014 Jun; 48(3):508-20. PubMed ID: 25119946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the October 1995 pill scare in Grampian.
    Flett G; Gurney E; McKessock L; Reid J
    Br J Fam Plann; 1998 Apr; 24(1):18-20. PubMed ID: 9719702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
    Chung T; Leung P; Cheung LP; Haines C; Chang AM
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Incidence of Abortion in Nigeria.
    Bankole A; Adewole IF; Hussain R; Awolude O; Singh S; Akinyemi JO
    Int Perspect Sex Reprod Health; 2015 Dec; 41(4):170-81. PubMed ID: 26871725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Unsafe abortion in Pernambuco State, Brazil, 1996-2006].
    de Mello FM; de Sousa JL; Figueroa JN
    Cad Saude Publica; 2011 Jan; 27(1):87-93. PubMed ID: 21340107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sexual violence in Congo-Kinshasa: necessity of decriminalizing abortion].
    Kalonda JC
    Rev Med Brux; 2012; 33(5):482-6. PubMed ID: 23167138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Demographic characteristics of women with self use of misoprostol for pregnancy interruption attending Maharaj Nakorn Chiang Mai Hospital.
    Pongsatha S; Morakot N; Tongsong T
    J Med Assoc Thai; 2002 Oct; 85(10):1074-80. PubMed ID: 12501898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion.
    Briozzo L; Vidiella G; Rodríguez F; Gorgoroso M; Faúndes A; Pons JE
    Int J Gynaecol Obstet; 2006 Nov; 95(2):221-6. PubMed ID: 17010348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repeat induced abortions in Georgia, characteristics of women with multiple pregnancy terminations: secondary analysis of the Reproductive Health Survey 2010.
    Pestvenidze E; Berdzuli N; Lomia N; Gagua T; Umikashvili L; Stray-Pedersen B
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():85-90. PubMed ID: 27567533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Motives and circumstances surrounding induced abortion among women living with HIV in Brazil].
    Villela WV; Barbosa RM; Portella AP; de Oliveira LA
    Cien Saude Colet; 2012 Jul; 17(7):1709-19. PubMed ID: 22872332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
    el-Refaey H; Rajasekar D; Abdalla M; Calder L; Templeton A
    N Engl J Med; 1995 Apr; 332(15):983-7. PubMed ID: 7885426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
    Peyron R; Aubény E; Targosz V; Silvestre L; Renault M; Elkik F; Leclerc P; Ulmann A; Baulieu EE
    N Engl J Med; 1993 May; 328(21):1509-13. PubMed ID: 8479487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreasing the need for abortion: challenges and constraints.
    Benagiano G; Pera A
    Int J Gynaecol Obstet; 2000 Jul; 70(1):35-48. PubMed ID: 10884532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induced abortion among women attending antenatal clinics in Yaounde, Cameroon.
    Mosoko JJ; Delvaux T; Glynn JR; Zekeng L; Macauley I; Buve A
    East Afr Med J; 2004 Feb; 81(2):71-7. PubMed ID: 15125089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.